Evidence map›Paper›PMID 30939750›Full record

ArticleInternational journal of molecular sciences2019

Rosiglitazone Enhances Browning Adipocytes in Association with MAPK and PI3-K Pathways During the Differentiation of Telomerase-Transformed Mesenchymal Stromal Cells into Adipocytes.

Abeer Maher Fayyad, Amir Ali Khan, Sallam Hasan Abdallah, Sara Sultan Alomran, Khalid Bajou, Muhammad Nasir Khan Khattak

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Biosynthesized Silver Nanoparticles fromCurrent pharmaceutical biotechnology · 2024
    Article
  13. International journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Generation of Mesenchymal Cell Lines Derived from Aged Donors.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Abeer Maher FayyadDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah 27272, UAE. u15200250@sharjah.ac.ae.
Amir Ali KhanDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah 27272, UAE. amkhan@sharjah.ac.ae.
Sallam Hasan AbdallahHuman Genetics & Stem cells research group, Research Institute of Sciences & Engineering, University of Sharjah, Sharjah 27272, UAE. sallam.abdallah@sharjah.ac.ae.
Sara Sultan AlomranDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah 27272, UAE. u16101513@sharjah.ac.ae.
Khalid BajouDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah 27272, UAE. kbajou@sharjah.ac.ae.
Muhammad Nasir Khan KhattakDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah 27272, UAE. mnasir@sharjah.ac.ae.
University of Sharjah · AE

Funding

College of Graduate Studies and Research by University of Sharjah and also by the Competitive Research Project Grant, grant number: 1602145036-P from University of Sharjah grant number: 1602145036-P
6 · The paper itself

Abstract

Obesity is a major risk for diabetes. Brown adipose tissue (BAT) mediates production of heat while white adipose tissue (WAT) function in the storage of fat. Roles of BAT in the treatment of obesity and related disorders warrants more investigation. Peroxisome proliferator activator receptor gamma (PPAR-γ) is the master regulator of both BAT and WAT adipogenesis and has roles in glucose and fatty acid metabolism. Adipose tissue is the major expression site for PPAR-γ. In this study, the effects of rosiglitazone on the brown adipogenesis and the association of MAPK and PI3K pathways was investigated during the in vitro adipogenic differentiation of telomerase transformed mesenchymal stromal cells (iMSCs). Our data indicate that 2 µM rosiglitazone enhanced adipogenesis by over-expression of PPAR-γ and C/EBP-α. More specifically, brown adipogenesis was enhanced by the upregulation of EBF2 and UCP-1 and evidenced by multilocular fatty droplets morphology of the differentiated adipocytes. We also found that rosiglitazone significantly activated MAPK and PI3K pathways at the maturation stage of differentiation. Overall, the results indicate that rosiglitazone induced overexpression of PPAR-γ that in turn enhanced adipogenesis, particularly browning adipogenesis. This study reports the browning effects of rosiglitazone during the differentiation of iMSCs into adipocytes in association with the activation of MAPK and PI3K signaling pathways.

Indexed as

AdipogenesisMAP Kinase Signaling SystemAdipocytes, BrownBasic Helix-Loop-Helix ProteinsCCAAT-Enhancer-Binding Protein-alphaCell LineHumansHypoglycemic AgentsMesenchymal Stem CellsPhosphatidylinositol 3-KinasesPPAR gammaRosiglitazoneUncoupling Protein 1Basic Helix-Loop-Helix ProteinsCCAAT-Enhancer-Binding Protein-alphaEbf2 protein, mouseHypoglycemic AgentsPhosphatidylinositol 3-KinasesPPAR gammaRosiglitazoneUcp1 protein, mouseUncoupling Protein 1brown adipocytesMAP kinase pathwayPI-3 kinase pathwayPPAR-γrosiglitazonetelomerase-transformed mesenchymal stromal cells (iMSC3)UCP-1

Identifiers

PMID30939750
PMCPMC6480475
OpenAlexW2933811723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.